Standard Operating Procedure for Prefilled Syringe Development and Compatibility Testing in Sterile Injectable Manufacturing
| Department | Sterile Injectable Manufacturing |
|---|---|
| SOP No. | SOP/SIM/016/2025 |
| Supersedes | SOP/SIM/016/2022 |
| Page No. | Page 1 of 15 |
| Issue Date | 18/06/2025 |
| Effective Date | 20/06/2025 |
| Review Date | 18/06/2026 |
1. Purpose
To establish a standard procedure for the development of prefilled syringe (PFS) formulations and conduct compatibility studies to ensure product safety, container-closure integrity, and stability.
2.
Scope
This SOP applies to the formulation development team, packaging development, analytical development, and quality assurance personnel involved in PFS design, formulation filling trials, and compatibility studies within sterile injectable manufacturing.
3. Responsibilities
- Formulation Scientist: Develops stable PFS-compatible formulations.
- Packaging Development Officer: Selects appropriate syringe system and evaluates material compatibility.
- Analytical Chemist: Performs extractable/leachable, stability, and physicochemical testing.
- QA Department: Verifies compliance with regulatory and GMP guidelines.
4. Accountability
The Head of R&D is accountable for successful development and compatibility validation of prefilled syringe systems for injectable products as per regulatory and GMP requirements.
5. Procedure
5.1 Prefilled Syringe Component Selection
- Select syringe type (e.g., glass, cyclic olefin polymer, siliconized) based on drug product compatibility.
- Consider factors such as:
- Drug adsorption to barrel material
- Plunger stopper compatibility
- Lubrication effects (e.g., silicone oil)
- Document material specifications (Annexure-1).
5.2 Formulation Design
- Ensure isotonicity, pH range (4.5–7.5), low viscosity, and absence of particulates.
- Design solution to minimize interaction with syringe components.
- Perform forced degradation to understand reactive sites.
5.3 Compatibility Studies
- Perform Extractables and Leachables (E&L) studies under ICH conditions.
- Analyze for:
- Siloxanes from siliconized components
- Heavy metals or polymers
- Label adhesive or ink migration
- Record results in the Compatibility Data Log (Annexure-2).
5.4 Syringe Filling Trials
- Fill pilot batches using aseptic technique or terminal sterilization if applicable.
- Inspect for defects: cracks, silicon oil droplets, plunger movement.
- Check plunger glide force and hold-up volume (residual volume).
5.5 Container Closure Integrity Testing (CCIT)
- Test seal integrity using:
- Vacuum Decay
- Dye Ingress
- Helium Leak Detection (for critical drugs)
- Document CCIT test results in Annexure-3.
5.6 Stability Study in Prefilled Syringes
- Conduct real-time and accelerated stability as per ICH Q1A guidelines.
- Test parameters:
- Appearance, assay, degradation products
- Extractables/leachables at T0, T1, T3, T6 months
- CCIT post-exposure
5.7 Documentation and Reporting
- Compile the Formulation and Compatibility Report (Annexure-4).
- Submit development summary to QA for archiving.
6. Abbreviations
- PFS: Prefilled Syringe
- CCIT: Container Closure Integrity Testing
- ICH: International Council for Harmonisation
- E&L: Extractables and Leachables
- QA: Quality Assurance
7. Documents
- Syringe Material Specification Sheet – Annexure-1
- Compatibility Study Data Log – Annexure-2
- CCIT Summary Report – Annexure-3
- Formulation & Compatibility Report – Annexure-4
8. References
- ICH Q1A(R2): Stability Testing
- ICH Q9: Quality Risk Management
- USP <1207>: Container Closure Integrity Testing
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | Formulation Scientist | QA Officer | R&D Head |
| Department | R&D | Quality Assurance | Sterile Injectables |
11. Annexures
Annexure-1: Syringe Material Specification Sheet
| Component | Material | Supplier | Tested By |
|---|---|---|---|
| Barrel | Glass Type I | Gerresheimer | Sunita Reddy |
| Plunger | Bromobutyl | West Pharma | Rajesh Kumar |
Annexure-2: Compatibility Study Data Log
| Batch No. | Study Condition | Observation | Analyst |
|---|---|---|---|
| PFS-B-001 | 40°C/75%RH – 1M | No change | Arvind Joshi |
Annexure-3: CCIT Summary Report
| Test Method | Batch No. | Result | Performed By |
|---|---|---|---|
| Vacuum Decay | PFS-B-001 | Pass | Sunita Reddy |
Annexure-4: Formulation & Compatibility Report
| Product | Drug-X Prefilled Syringe |
|---|---|
| Batch No. | PFS-DEV-001 |
| Prepared By | Rajesh Kumar |
| Date | 10/06/2025 |
Revision History
| Revision Date | Revision No. | Details | Reason | Approved By |
|---|---|---|---|---|
| 05/01/2022 | 1.0 | Initial SOP release | New development procedure | QA Manager |
| 18/06/2025 | 2.0 | Added CCIT and E&L details | Regulatory compliance | QA Manager |